INTRODUCTION
International Classification of Sleep Disorders, 3rd edition (ICSD-3) distinct insomnia to acute and chronic (insomnia symptoms >3 nights per week for >3 months).1 Various symptoms of sleep disorders comprise difficulty initiating sleep, difficulty maintaining sleep, and nonrestorative sleep.2 Prevalence of insomnia is alarming high as it affects 6% to 10% of the adult population.3 Insomnia is more prevalent in females and older individuals.4 Besides primary insomnia, comorbid sleep disorders are also common accompanying different diseases/conditions, e.g., chronic pain, nocturia, chronic cough, pruritus, emotional trauma, and pregnancy.5,6 Sleep difficulties are also common complaints of shift workers. If not adequately treated, insomnia can result in psychopathological conditions, hypertension, and other serious health problems.7 Treatment options for insomnia cover pharmacological and non-pharmacological approaches. Commonly used agents are benzodiazepine receptor agonists, sedating antidepressants, sedating antihistamines, melatonin receptor agonists, and dual orexin receptor antagonists.7 However, all medications are associated with their potential side effects. Being aware of the possible side effects of hypnotic/sedating drugs is particularly important in elderly patients. Regarding geriatric patients using hypnotic/sedating medication, an increased risk of falls, physical dependence, and confusion have been documented.8 Considering the possible adverse effects of the above-mentioned agents, a non-pharmacologic approach should be preferred in most cases.9 Of the patients presenting with insomnia symptoms, most do not require sleep specialist referral and can be managed by general practitioners.10Notably, in relation to the COVID-19 pandemic, 43.5% of sleep departments in the Czech Republic and Slovakia completely interrupted their service. In similar situations, primary care physicians may need to manage insomnia symptoms even in more complicated cases.11 Multicomponent behavioral therapy and psychotherapy are considered first-line treatment according to guidelines of the American College of Physicians, European Sleep Research Society, and British Association for Psychopharmacology.12,13,14 The non-pharmacological treatment components are cognitive-behavioral therapy for insomnia (CBT-i), sleep hygiene, stimulus control, sleep restriction, psychotherapy and relaxation techniques, exercise, complementary and alternative approaches, e.g., phototherapy, massage, music therapy, aromatherapy, herbal medicine, acupuncture/acupressure.